Cite
HARVARD Citation
Kang, Y. et al. (2021). Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study. Journal of clinical oncology. 39 (28), pp. 3128-3139. [Online].